Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-26

Clinical Trial Update: Brillant Blue Versus Indocyanine Green for Macular Hole Surgery [NA]

View source ↗

Summary

Clinical trial comparing Brilliant Blue G dye versus Indocyanine Green dye in macular hole surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brillant Blue (Brilliant Blue G)
  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Idiopathic Macular Holes | NA | Status: COMPLETED